omniture
logo
Search
凌科药业（杭州）有限公司 Lingke Pharmaceutical
Media Room

Latest News

rss

Lynk Pharmaceuticals Announced First Patient Dosed in Phase I Clinical Study of Its Triple-Kinase Inhibitor LNK01002

HANGZHOU, China, Aug. 12, 2021 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred...

2021-08-12 08:00 3152

Lynk Pharmaceuticals Announced Clinical Approval in China of Its New Class I Drug LNK01003

HANGZHOU, China, June 25, 2021 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred...

2021-06-25 15:11 3036

Lynk Pharmaceuticals enters exclusive licensing agreements with Kobe University and with RIKEN Research Institute to develop RAS inhibitors with a novel MOA

HANGZHOU, China, July 27, 2020 /PRNewswire/ -- Lynk Pharmaceuticals (Hangzhou, China) is pleased to...

2020-07-27 07:00 3827
12